UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.27B
| $72.9M | 0.01% |
256,859
+10,474
| +4% | +$2.83M |
2014 Q4
46 quarters
|
|
1377
WillScot Mobile Mini Holdings
WSC
$3.55B
| $72.9M | 0.01% |
2,525,357
+350,043
| +16% | +$8.47M |
2017 Q4
34 quarters
|
|
1378
Coca-Cola Consolidated
COKE
$13.7B
| $72.8M | 0.01% |
381,565
+186,861
| +96% | +$34.8M |
2014 Q4
46 quarters
|
|
1379
Fluor
FLR
$6.42B
| $72.6M | 0.01% |
1,386,326
-759,363
| -35% | -$37.2M |
2014 Q4
46 quarters
|
|
1380
Macy's
M
$6.24B
| $72.6M | 0.01% |
3,083,504
-163,301
| -5% | -$3.42M |
2014 Q4
46 quarters
|
|
1381
Teva Pharmaceutical Industries Limited
TEVA
$48.9B
| $72.5M | 0.01% |
2,140,065
+262,848
| +14% | +$8.75M |
2014 Q4
46 quarters
|
|
1382
Willis Towers Watson
WTW
$30.2B
| $72.4M | 0.01% |
277,095
-4,755
| -2% | -$1.27M |
2014 Q4
46 quarters
|
|
1383
PUT
Goldman Sachs
GS
$261B
| $72.3M | 0.01% |
71,500
-113,900
| -61% | -$111M |
2014 Q4
46 quarters
|
|
1384
Graphic Packaging
GPK
$3.35B
| $72.3M | 0.01% |
6,840,158
-752,615
| -10% | -$7.68M |
2014 Q4
46 quarters
|
|
1385
KeyCorp
KEY
$22.5B
| $72.2M | 0.01% |
3,134,278
-3,743,545
| -54% | -$81.6M |
2014 Q4
46 quarters
|
|
1386
Sanofi
SNY
$109B
| $72.2M | 0.01% |
1,693,442
+709,596
| +72% | +$31.7M |
2014 Q4
46 quarters
|
|
1387
LKQ Corp
LKQ
$4.86B
| $72.2M | 0.01% |
2,740,395
-1,276,874
| -32% | -$35.5M |
2014 Q4
46 quarters
|
|
1388
Stifel
SF
$10.3B
| $72M | 0.01% |
1,032,580
+247,505
| +32% | +$18.5M |
2014 Q4
46 quarters
|
|
1389
Allegion
ALLE
$16.1B
| $72M | 0.01% |
512,542
-229,662
| -31% | -$31.2M |
2014 Q4
46 quarters
|
|
1390
Main Street Capital
MAIN
$5.27B
| $72M | 0.01% |
1,387,731
+48,919
| +4% | +$2.58M |
2014 Q4
46 quarters
|
|
1391
MGM Resorts International
MGM
$7.85B
| $72M | 0.01% |
1,505,621
+86,607
| +6% | +$3.6M |
2014 Q4
46 quarters
|
|
1392
Wingstop
WING
$4.37B
| $71.9M | 0.01% |
414,861
+182,253
| +78% | +$28.7M |
2015 Q2
44 quarters
|
|
1393
CALL
Colgate-Palmolive
CL
$76B
| $71.9M | 0.01% |
783,828
+476,100
| +155% | +$41.7M |
2022 Q2
16 quarters
|
|
1394
CRISPR Therapeutics
CRSP
$4.83B
| $71.9M | 0.01% |
1,317,499
-445,031
| -25% | -$23.5M |
2016 Q4
38 quarters
|
|
1395
CALL
Deutsche Bank
DB
$63.1B
| $71.8M | 0.01% |
2,127,804
-1,258,756
| -37% | -$40.8M |
2014 Q4
46 quarters
|
|
1396
Nova
NVMI
$9.6B
| $71.8M | 0.01% |
132,269
-12,744
| -9% | -$6.55M |
2015 Q1
45 quarters
|
|
1397
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$3.96B
| $71.7M | 0.01% |
957,300
-3,642,200
| -79% | -$255M |
2017 Q4
34 quarters
|
|
1398
CALL
Vale
VALE
$46.7B
| $71.6M | 0.01% |
4,763,067
+1,978,200
| +71% | +$32.2M |
2014 Q4
46 quarters
|
|
1399
TransUnion
TRU
$15B
| $71.6M | 0.01% |
992,499
+46,356
| +5% | +$3.25M |
2015 Q2
44 quarters
|
|
1400
iShares CMBS ETF
CMBS
$444M
| $71.5M | 0.01% |
1,469,948
-187,101
| -11% | -$9.1M |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.